Pandemic Response

Learn how the influenza community is responding to COVID-19

Learn More

Convergence Science Agenda

We’re bringing together intellectual, investment and technology communities and expertise to accelerate development of a universal influenza vaccine.

A New Paradigm for an Age-Old Problem: The Threat of Influenza

The ‘Convergence Research’ paradigm combines previously distinct knowledge and methods from across the science and technology landscape to shape novel pathways and innovative approaches for overcoming long-standing and vexing societal challenges. Using this framework, next-generation influenza vaccines are Sabin’s target. Building on recommendations of the Sabin-Aspen Vaccine Science & Policy Group, our work will convene a diverse and bold set of thinkers and leaders to stimulate the expanded intellectual and capital investment required to transform vaccine protection against the threat of influenza.

Emerging Convergence Scholarship

Advancing emerging opportunities for next-generation influenza vaccines will require the engagement of the next generation of scientific and technology leaders. Sabin is supporting three innovative graduate-level students to contribute to developing our Convergence Science Agenda as Emerging Convergence Scholars. Awardees will attend a working group meeting where emerging scholars will have the opportunity to engage with transdisciplinary experts as they collaborate to build a Convergence Science Agenda and to share these ideas and their experience through multimedia channels, inclusive of Sabin’s Influenzer community.

Currently not accepting applications due to COVID19 restrictions.